Table 2: Identified DNA variants and the Hardy-Weinberg equilibrium of 10 SNPs in the TNNT2 gene in the DCM patients and control subjects.

Markers Location of nucleotide change Amino acid change Note Obs HET Expt HET HWE (P) MAF rs7521796 Intron 201330019 A>G Noncoding Novel noncoding SNP 0.115 0.115 1 0.061 rs2275862 Intron 201330366 C>G Non-coding Novel non-coding SNP 0.329 0.319 0.7683 0.199 rs3729547 201334382 T>C Synonymous Ile [I] Reported synonymous 0.504 0.484 1 0.41 rs10800775 Intron 201336386 C>T Non-coding Novel non-coding SNP 0.474 0.448 0.771 0.339 rs1892028 Intron 201336641 A>G Non-coding Novel non-coding SNP 0.489 0.498 0.7396 0.47 rs3729843 Intron 201336984 G>A Non-coding Reported non-coding SNP 0.285 0.331 0.5949 0.21 rs3729842 Intron 201337170 C>T Non-coding Reported non-coding SNP 0.225 0.241 0.3594 0.14 rs12563114 Intron 201344908 C>T Non-coding Novel non-coding SNP 0.081 0.084 0.5638 0.044 rs12564445 Intron 201345487 G>A Non-coding Novel non-coding SNP 0.435 0.427 0.7891 0.309 rs4915232 5′ near gene 201347946 A>G Non-coding Novel non-coding SNP 0.535 0.499 0.7407 0.482

Note: Obs HET: observed heterozygosity, Expt HET: expected heterozygosity, HWE (P): P value from the Hardy-Weinberg equilibrium test, and MAF: minor allele frequency.